Balance Sheet LINTEC Corporation

Stocks

7966

JP3977200009

Specialty Chemicals

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-12 am EDT			5-day change	1st Jan Change
5,740.00 ^JPY	+2.87%		-0.35%	+29.86%

May. 21	Lintec Corporation Establishes Lintec Tsukuba Innovative Creation Center	CI
May. 08	LINTEC Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI

4a1a2f56f2d33d8b78.MfsUs3wPmohW4HDGheFScbmGAuV-Uda_-rgSaycnkas.W5pegyhYru57qj-LwqQiEP_RTIYHE4ntj_t8ERFto51CtFr5HmDqxCe4MQ

Published financial data: LINTEC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	236B	257B	285B	276B	316B
Total Revenues	236B	257B	285B	276B	316B
Cost of Goods Sold, Total	178B	192B	221B	215B	236B
Gross Profit	58.23B	65.14B	63.18B	61.41B	79.84B
Selling General & Admin Expenses, Total	31.87B	33.89B	38.22B	39.56B	42.81B
Provision for Bad Debts	21M	6M	21M	8M	-23M
R&D Expenses	7.62B	7.88B	9.07B	9.04B	10.06B
Depreciation & Amortization - (IS)	1.68B	1.78B	2.07B	2.18B	2.43B
Other Operating Expenses, Total	41.2B	43.55B	49.38B	50.78B	55.28B
Operating Income	17.03B	21.58B	13.8B	10.63B	24.56B
Interest Expense, Total	-149M	-110M	-116M	-398M	-305M
Interest And Investment Income	216M	417M	403M	650M	1.02B
Net Interest Expenses	67M	307M	287M	252M	711M
Currency Exchange Gains (Loss)	-249M	1B	1.43B	692M	617M
Other Non Operating Income (Expenses)	288M	195M	406M	224M	356M
EBT, Excl. Unusual Items	17.14B	23.09B	15.92B	11.8B	26.25B
Gain (Loss) On Sale Of Investments	35M	531M	620M	-11M	316M
Gain (Loss) On Sale Of Assets	-366M	-392M	-334M	-233M	-83M
Asset Writedown	-171M	-	-347M	-1.02B	-7.73B
Other Unusual Items	-	1M	-1M	-1.09B	2M
EBT, Incl. Unusual Items	16.64B	23.23B	15.86B	9.45B	18.75B
Income Tax Expense	5.26B	6.55B	4.36B	4.19B	4.26B
Earnings From Continuing Operations	11.38B	16.68B	11.5B	5.26B	14.49B
Net Income to Company	11.38B	16.68B	11.5B	5.26B	14.49B
Minority Interest	29M	-41M	11M	-18M	-17M
Net Income - (IS)	11.41B	16.64B	11.51B	5.24B	14.48B
Net Income to Common Incl Extra Items	11.41B	16.64B	11.51B	5.24B	14.48B
Net Income to Common Excl. Extra Items	11.41B	16.64B	11.51B	5.24B	14.48B
Per Share Items
Net EPS - Basic	157.81	232.12	167.84	76.66	211.98
Basic EPS - Continuing Operations	157.81	232.12	167.84	76.66	211.98
Basic Weighted Average Shares Outstanding	72.28M	71.69M	68.59M	68.4M	68.29M
Net EPS - Diluted	157.69	231.96	167.74	76.63	211.89
Diluted EPS - Continuing Operations	157.69	231.96	167.74	76.63	211.89
Diluted Weighted Average Shares Outstanding	72.34M	71.74M	68.64M	68.43M	68.32M
Normalized Basic EPS	148.58	200.72	145.26	107.54	239.95
Normalized Diluted EPS	148.46	200.58	145.17	107.49	239.85
Dividend Per Share	78	88	88	88	100
Payout Ratio	49.37	33.9	55.82	114.76	44.4
Supplemental Items
EBITDA	29.5B	34.68B	28.69B	26.53B	41.92B
EBITA	20.14B	24.78B	17.54B	14.69B	29.1B
EBIT	17.03B	21.58B	13.8B	10.63B	24.56B
Effective Tax Rate - (Ratio)	31.6	28.18	27.49	44.33	22.72
Normalized Net Income	10.74B	14.39B	9.96B	7.36B	16.39B
Non-Cash Pension Expense	170M	67M	180M	-137M	-509M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.38B	5.97B	5.82B	5.24B	5.77B
Research And Development Expense From Footnotes	7.62B	7.88B	9.07B	9.04B	10.06B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	61.82B	55.42B	38.03B	55.49B	55.51B
Total Cash And Short Term Investments	61.82B	55.42B	38.03B	55.49B	55.51B
Accounts Receivable, Total	64.59B	62.29B	58.65B	64.58B	64.54B
Total Receivables	64.59B	62.29B	58.65B	64.58B	64.54B
Inventory	38.43B	52.54B	67.25B	59.55B	64.05B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	5.25B	11.79B	8.01B	8.36B	8.67B
Total Current Assets	170B	182B	172B	188B	193B
Net Property Plant And Equipment	79.81B	90.22B	102B	114B	117B
Long-term Investments	4.5B	4.09B	8.49B	8.42B	7.4B
Goodwill	16.98B	16.96B	15.01B	15.06B	11.77B
Other Intangibles, Total	2B	1.86B	2.7B	3.24B	3.16B
Deferred Tax Assets Long-Term	6.88B	7.4B	5.15B	4.82B	8.44B
Other Long-Term Assets, Total	-	1M	1M	2M	2M
Total Assets	280B	303B	305B	334B	340B
Liabilities
Accounts Payable, Total	44.84B	44.28B	36.98B	45.7B	40.35B
Accrued Expenses, Total	53M	2.71B	2.58B	2.45B	2.79B
Short-term Borrowings	1.52B	1.29B	960M	1.4B	1.3B
Current Portion of Long-Term Debt	1.22B	1.35B	1.6B	1.97B	1.84B
Current Income Taxes Payable	3.41B	4.21B	1.29B	1.98B	5B
Other Current Liabilities	12.47B	18.47B	16.42B	22.42B	18.71B
Total Current Liabilities	63.51B	72.31B	59.82B	75.92B	69.99B
Long-Term Debt	2.55B	1.47B	-	5.89B	3.79B
Long-Term Leases	-	-	-	-	3.41B
Pension & Other Post Retirement Benefits	15.43B	15.94B	12.93B	13.67B	14.67B
Other Non Current Liabilities	1.43B	3.1B	4.98B	5.19B	2.48B
Total Liabilities	82.91B	92.81B	77.73B	101B	94.35B
Common Stock, Total	23.28B	23.32B	23.36B	23.36B	23.36B
Additional Paid In Capital	26.91B	26.94B	26.71B	26.7B	26.63B
Retained Earnings	155B	166B	171B	171B	170B
Treasury Stock	-7.58B	-14.12B	-17.66B	-17.57B	-11.7B
Comprehensive Income and Other	-903M	6.92B	22.71B	29B	37.12B
Total Common Equity	197B	209B	226B	232B	245B
Minority Interest	403M	451M	715M	703M	758M
Total Equity	197B	210B	227B	233B	246B
Total Liabilities And Equity	280B	303B	305B	334B	340B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	72.31M	68.99M	68.39M	68.42M	65.93M
ECS Total Common Shares Outstanding	72.29M	69.83M	68.36M	68.4M	67.35M
Book Value / Share	2.72K	3K	3.31K	3.4K	3.64K
Tangible Book Value	178B	190B	209B	214B	230B
Tangible Book Value Per Share	2.46K	2.73K	3.05K	3.13K	3.42K
Total Debt	5.28B	4.11B	2.56B	9.26B	10.34B
Net Debt	-56.54B	-51.31B	-35.47B	-46.23B	-45.17B
Debt Equivalent of Unfunded Proj. Benefit Obligation	15.43B	15.94B	9.16B	10.07B	11.66B
Minority Interest, Total (Incl. Fin. Div)	403M	451M	715M	703M	758M
Inventories - Raw Materials, Total	9.44B	15.56B	21.11B	15.14B	17.63B
Inventories - Work In Process, Total	14.86B	17.76B	23.81B	26.04B	25.43B
Inventories - Finished Goods, Total	14.13B	19.21B	22.33B	18.36B	20.99B
Inventories - Others	-	1M	-	-	1M
Full Time Employees	4.91K	5.16K	5.42K	5.48K	5.31K
Accumulated Allowance for Doubtful Accounts (Supple)	45M	62M	155M	181M	166M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	16.64B	23.23B	15.86B	9.45B	18.75B
Depreciation & Amortization - CF	9.36B	9.9B	11.14B	11.84B	12.82B
Amortization of Goodwill and Intangible Assets - (CF)	3.11B	3.2B	3.74B	4.06B	4.54B
Depreciation & Amortization, Total	12.47B	13.1B	14.89B	15.9B	17.36B
(Gain) Loss From Sale Of Asset	273M	197M	470M	1.1B	7.62B
(Gain) Loss on Sale of Investments - (CF)	-35M	-249M	-621M	5M	-261M
Other Operating Activities, Total	-4.55B	-6.53B	-7.52B	-3.35B	-4.71B
Change In Accounts Receivable	-2.02B	6.18B	5.61B	-3.13B	1.95B
Change In Inventories	1.47B	-8.55B	-11.75B	10.92B	-1.95B
Change In Accounts Payable	4.03B	-3.78B	-9.98B	6.24B	-5.9B
Change in Other Net Operating Assets	555M	1.04B	-1.02B	2.07B	835M
Cash from Operations	28.82B	24.64B	5.94B	39.2B	33.72B
Capital Expenditure	-9B	-8.52B	-12.55B	-14.43B	-23.76B
Sale of Property, Plant, and Equipment	27M	17M	79M	108M	436M
Cash Acquisitions	-	-6.35B	-	-1.09B	-
Divestitures	-	478M	586M	22M	-
Sale (Purchase) of Intangible assets	-451M	-210M	-1.18B	-497M	-385M
Investment in Marketable and Equity Securities, Total	741M	-385M	979M	1.33B	-1.01B
Net (Increase) Decrease in Loans Originated / Sold - Investing	5M	7M	-16M	-5M	-10M
Other Investing Activities, Total	63M	-4.68B	-38M	-6.95B	61M
Cash from Investing	-8.61B	-19.64B	-12.14B	-21.51B	-24.67B
Short Term Debt Issued, Total	-	-	-	485M	-
Long-Term Debt Issued, Total	1.35B	-	-	6.8B	-
Total Debt Issued	1.35B	-	-	7.28B	-
Short Term Debt Repaid, Total	-	-331M	-462M	-	-100M
Long-Term Debt Repaid, Total	-9.14B	-1.23B	-1.47B	-1.72B	-1.77B
Total Debt Repaid	-9.14B	-1.56B	-1.93B	-1.72B	-1.87B
Repurchase of Common Stock	-1M	-6.54B	-3.56B	-1M	-3.09B
Common Dividends Paid	-5.63B	-5.64B	-6.43B	-6.02B	-6.43B
Common & Preferred Stock Dividends Paid	-5.63B	-5.64B	-6.43B	-6.02B	-6.43B
Other Financing Activities, Total	-705M	-714M	-864M	-829M	-938M
Cash from Financing	-14.13B	-14.46B	-12.78B	-1.29B	-12.33B
Foreign Exchange Rate Adjustments	-706M	2.42B	2.23B	1.95B	1.59B
Miscellaneous Cash Flow Adjustments	-2M	-	-	179M	-
Net Change in Cash	5.38B	-7.03B	-16.75B	18.54B	-1.69B
Supplemental Items
Cash Interest Paid	163M	118M	122M	300M	333M
Cash Income Tax Paid (Refund)	4.66B	6.54B	7.58B	3.5B	4.66B
Levered Free Cash Flow	17.24B	8.34B	-9.98B	24.07B	-2.08B
Unlevered Free Cash Flow	17.34B	8.41B	-9.91B	24.32B	-1.89B
Change In Net Working Capital	-3.67B	9.44B	19.7B	-16.7B	10.46B
Net Debt Issued / Repaid	-7.79B	-1.56B	-1.93B	5.56B	-1.87B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.81	4.63	2.84	2.08	4.55
Return on Total Capital	5.22	6.48	3.89	2.82	6.16
Return On Equity %	5.84	8.2	5.26	2.29	6.05
Return on Common Equity	5.87	8.19	5.28	2.29	6.06
Margin Analysis
Gross Profit Margin %	24.68	25.36	22.2	22.22	25.27
SG&A Margin	13.51	13.19	13.43	14.32	13.55
EBITDA Margin %	12.51	13.5	10.08	9.6	13.27
EBITA Margin %	8.54	9.65	6.16	5.32	9.21
EBIT Margin %	7.22	8.4	4.85	3.85	7.77
Income From Continuing Operations Margin %	4.82	6.5	4.04	1.9	4.59
Net Income Margin %	4.84	6.48	4.04	1.9	4.58
Net Avail. For Common Margin %	4.84	6.48	4.04	1.9	4.58
Normalized Net Income Margin	4.55	5.6	3.5	2.66	5.19
Levered Free Cash Flow Margin	7.31	3.25	-3.51	8.71	-0.66
Unlevered Free Cash Flow Margin	7.35	3.27	-3.48	8.8	-0.6
Asset Turnover
Asset Turnover	0.84	0.88	0.94	0.87	0.94
Fixed Assets Turnover	2.94	3.02	2.97	2.56	2.74
Receivables Turnover (Average Receivables)	3.7	4.05	4.71	4.48	4.89
Inventory Turnover (Average Inventory)	4.51	4.21	3.7	3.39	3.82
Short Term Liquidity
Current Ratio	2.68	2.52	2.87	2.48	2.75
Quick Ratio	1.99	1.63	1.62	1.58	1.72
Operating Cash Flow to Current Liabilities	0.45	0.34	0.1	0.52	0.48
Days Sales Outstanding (Average Receivables)	98.56	90.16	77.55	81.61	74.57
Days Outstanding Inventory (Average Inventory)	81.01	86.6	98.73	107.97	95.53
Average Days Payable Outstanding	89.65	79.03	62.8	73.02	65.26
Cash Conversion Cycle (Average Days)	89.92	97.73	113.47	116.56	104.84
Long Term Solvency
Total Debt/Equity	2.67	1.96	1.13	3.98	4.2
Total Debt / Total Capital	2.61	1.92	1.12	3.82	4.03
LT Debt/Equity	1.29	0.7	-	2.53	2.93
Long-Term Debt / Total Capital	1.26	0.69	-	2.43	2.81
Total Liabilities / Total Assets	29.58	30.67	25.5	30.17	27.71
EBIT / Interest Expense	114.3	196.22	118.94	26.71	80.53
EBITDA / Interest Expense	198	315.26	247.3	66.66	137.46
(EBITDA - Capex) / Interest Expense	137.62	237.79	139.12	30.4	59.55
Total Debt / EBITDA	0.18	0.12	0.09	0.35	0.25
Net Debt / EBITDA	-1.92	-1.48	-1.24	-1.74	-1.08
Total Debt / (EBITDA - Capex)	0.26	0.16	0.16	0.77	0.57
Net Debt / (EBITDA - Capex)	-2.76	-1.96	-2.2	-3.82	-2.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2	8.87	10.81	-2.91	14.35
Gross Profit, 1 Yr. Growth %	-0.36	11.86	-3.01	-2.8	30.02
EBITDA, 1 Yr. Growth %	4.63	17.55	-17.28	-7.52	58.02
EBITA, 1 Yr. Growth %	7.68	23.05	-29.22	-16.24	98.07
EBIT, 1 Yr. Growth %	10.3	26.73	-36.08	-22.96	131.08
Earnings From Cont. Operations, 1 Yr. Growth %	18.86	46.62	-31.06	-54.26	175.48
Net Income, 1 Yr. Growth %	18.58	45.88	-30.82	-54.46	176.1
Normalized Net Income, 1 Yr. Growth %	10.99	33.99	-30.76	-26.18	122.79
Diluted EPS Before Extra, 1 Yr. Growth %	18.52	47.1	-27.69	-54.32	176.51
Accounts Receivable, 1 Yr. Growth %	2.83	-3.56	-5.85	10.12	-0.07
Inventory, 1 Yr. Growth %	-4.95	36.7	28.01	-11.45	7.57
Net Property, Plant and Equip., 1 Yr. Growth %	-0.84	13.05	12.6	12.34	2.46
Total Assets, 1 Yr. Growth %	0.46	7.96	0.77	9.43	2.05
Tangible Book Value, 1 Yr. Growth %	5.72	7.04	9.58	2.52	7.69
Common Equity, 1 Yr. Growth %	2.65	6.27	8.18	2.58	5.63
Cash From Operations, 1 Yr. Growth %	55.8	-14.51	-75.91	560.46	-14
Capital Expenditures, 1 Yr. Growth %	-27.69	-5.28	47.25	15	64.65
Levered Free Cash Flow, 1 Yr. Growth %	279.27	-51.63	-219.71	-341.06	-108.66
Unlevered Free Cash Flow, 1 Yr. Growth %	272.21	-51.5	-217.87	-345.33	-107.78
Dividend Per Share, 1 Yr. Growth %	0	12.82	0	0	13.64
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.04	3.29	9.84	3.72	5.37
Gross Profit, 2 Yr. CAGR %	-2.52	5.57	4.16	-2.9	12.42
EBITDA, 2 Yr. CAGR %	-0.79	10.9	-1.39	-12.53	20.89
EBITA, 2 Yr. CAGR %	-2.7	15.11	-6.67	-23	28.81
EBIT, 2 Yr. CAGR %	-2.67	18.23	-9.99	-29.83	33.43
Earnings From Cont. Operations, 2 Yr. CAGR %	-6.16	32.01	0.54	-43.84	12.26
Net Income, 2 Yr. CAGR %	-6.1	31.52	0.46	-43.87	12.14
Normalized Net Income, 2 Yr. CAGR %	-4.63	21.95	-3.68	-28.51	28.24
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.13	32.04	3.14	-42.52	12.39
Accounts Receivable, 2 Yr. CAGR %	-3.52	-0.42	-4.71	1.82	4.9
Inventory, 2 Yr. CAGR %	-2.85	13.99	32.28	6.46	-2.41
Net Property, Plant and Equip., 2 Yr. CAGR %	3.06	5.88	12.83	12.47	7.28
Total Assets, 2 Yr. CAGR %	-1.75	4.14	4.3	5.01	5.68
Tangible Book Value, 2 Yr. CAGR %	4.93	6.38	8.3	5.99	5.07
Common Equity, 2 Yr. CAGR %	1.88	4.45	7.23	5.35	4.1
Cash From Operations, 2 Yr. CAGR %	12.29	15.41	-54.62	26.13	138.32
Capital Expenditures, 2 Yr. CAGR %	-8.59	-17.24	18.1	30.13	37.6
Levered Free Cash Flow, 2 Yr. CAGR %	30.61	35.44	-23.91	69.88	-54.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.18	34.37	-24.39	70.05	-56.3
Dividend Per Share, 2 Yr. CAGR %	0	6.22	6.22	0	6.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.79	0.78	5.74	5.41	7.15
Gross Profit, 3 Yr. CAGR %	-2.5	2.06	2.63	1.79	7.02
EBITDA, 3 Yr. CAGR %	-3.23	4.98	0.58	-3.48	6.53
EBITA, 3 Yr. CAGR %	-5.04	5.22	-2.12	-9.98	5.5
EBIT, 3 Yr. CAGR %	-5.37	6.28	-3.68	-14.54	4.4
Earnings From Cont. Operations, 3 Yr. CAGR %	0.68	8.89	6.31	-22.67	-4.58
Net Income, 3 Yr. CAGR %	0.44	8.75	6.17	-22.83	-4.54
Normalized Net Income, 3 Yr. CAGR %	-3.68	6.81	0.98	-11.85	4.43
Diluted EPS Before Extra, 3 Yr. CAGR %	0.41	9.03	8.03	-21.38	-2.97
Accounts Receivable, 3 Yr. CAGR %	-3.77	-3.54	-2.26	-0	1.19
Inventory, 3 Yr. CAGR %	-0.06	8.87	18.48	15.72	6.83
Net Property, Plant and Equip., 3 Yr. CAGR %	1.94	6.29	8.07	12.66	9.03
Total Assets, 3 Yr. CAGR %	-1.44	1.39	3	5.98	4.01
Tangible Book Value, 3 Yr. CAGR %	5.07	5.63	7.43	6.34	6.55
Common Equity, 3 Yr. CAGR %	1.94	3.33	5.68	5.65	5.44
Cash From Operations, 3 Yr. CAGR %	2.43	2.54	-31.54	10.8	11.02
Capital Expenditures, 3 Yr. CAGR %	3.63	-7.5	0.28	17.06	40.75
Levered Free Cash Flow, 3 Yr. CAGR %	-2.16	-6.21	29.98	11.76	-37.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.23	-6.33	28.63	11.94	-39.17
Dividend Per Share, 3 Yr. CAGR %	5.73	4.1	4.1	4.1	4.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.3	4.51	2.71	1.95	5.59
Gross Profit, 5 Yr. CAGR %	1.66	4.27	0.11	0.04	6.44
EBITDA, 5 Yr. CAGR %	2.12	7.3	-2.5	-2.41	8.26
EBITA, 5 Yr. CAGR %	2.54	7.94	-5.7	-7.13	9.25
EBIT, 5 Yr. CAGR %	-0.76	5.4	-7.25	-9.98	9.73
Earnings From Cont. Operations, 5 Yr. CAGR %	1.1	8.28	0.62	-16.45	8.65
Net Income, 5 Yr. CAGR %	0.92	7.76	0.45	-16.53	8.52
Normalized Net Income, 5 Yr. CAGR %	-1.12	6.46	-3.68	-9.03	11.11
Diluted EPS Before Extra, 5 Yr. CAGR %	0.89	7.92	1.49	-15.6	9.75
Accounts Receivable, 5 Yr. CAGR %	0.76	-1.36	-4.15	-1.43	0.54
Inventory, 5 Yr. CAGR %	4.35	8.72	11.8	7.9	9.64
Net Property, Plant and Equip., 5 Yr. CAGR %	4.24	4.08	6.16	8.72	7.76
Total Assets, 5 Yr. CAGR %	3.09	1.99	0.82	2.82	4.06
Tangible Book Value, 5 Yr. CAGR %	1.06	6.43	6.35	5.77	6.48
Common Equity, 5 Yr. CAGR %	2.84	3.29	4.02	4.13	5.04
Cash From Operations, 5 Yr. CAGR %	7.66	0.23	-26.04	11.39	12.75
Capital Expenditures, 5 Yr. CAGR %	-1.72	-8.17	9.19	6.03	13.81
Levered Free Cash Flow, 5 Yr. CAGR %	7.47	28.29	-11.52	18.95	-14.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.57	28.02	-11.78	18.91	-16.48
Dividend Per Share, 5 Yr. CAGR %	7.63	5.92	5.92	2.44	5.09